Efficacy of Kanpo Therapy in Ulcerative Colitis
Efficacy of Kanpo Therapy in Ulcerative Colitis
批准号:
02045005
负责人:
TAKAHASI Tuneo
金额:
$2.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for international Scientific Research
财政年份:
1990
资助国家:
日本
项目状态:
已结题
起止时间:
1990 至 1991
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Ulcerative colitis (UC) is supposed to have the immunological abnormalities and is treated mainly with salicyl-azosulfapyridine (SASP) and corricosteroid hormone (CS). We investigated the effect of Saireito (Chinese traditional medicine) on improving the immunological deficiency of the chemiluminescent response (CL) and cultured T lymphocyte function derived from UC patient.One third patient with active UC stage were improved by Saireito therapy combined with CS or SASP. The activity of CL was increased in UC group compared with healthy control group. The CL activities were decreased after p. o. administration of Saireito.The cultured T cell line derived from active UC patients were expressed CD4 positive marker and more responded CD3 antibody compared with control group. Saireitou was efficient to suppress the proliferative response in vitro. The production of TNF in established T cell line from UC patient was higher than the cell line from normal mucosa. The production of TNF was also suppressed by Saireito solution similar to corticosteroid effect.Saireito suppressed the CL activities of neutrophils after p. o. administration. The study on T cell lymmphocyte function suggested the possibility that Saireito has some influence on immune function. On the basis of these results, we suggest that Saireito might be able to use treatment of UC not only for reducing the dose of CS or SASP but improving the immune deficiency of UC.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Takahashi,T.,Ajitsu.S.,et al.: "Kanpo therapy in ulcerative colitis in special reference of immunological effects of Saireito." Yamagata Medical Journal 発表予定. 9. (1991)
Takahashi, T., Ajitsu, et al.:“溃疡性结肠炎的汉方疗法特别参考 Saireito 的免疫学作用”,即将出版 9。(1991 年)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
海外基金